Ovid Therapeutics Inc (OVID) stock news · $23.5M cap
Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.
This OVID news page leads with what Ovid Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for OVID yet. We will not pad this page with generic market recap.
Latest reported OVID revenue for 2026-06-30 was $733.0K. Net income was -$15.0M. OVID currently screens at market cap $23.5M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the OVID stock page; for the tape open the quote page.
OVID stock news FAQ
What are OVID's latest revenue and net income?
Latest cached Ovid Therapeutics Inc (OVID) revenue for Jun 30, 2026 was $733.0K. Net income was -$15.0M. Statements: https://lician.com/financials/ovid
What is OVID's market cap?
Ovid Therapeutics Inc (OVID) market cap is $23.5M on the latest cached fundamentals snapshot.
What kind of company is OVID?
Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.
Where is OVID stock news listed?
Cached stock news for Ovid Therapeutics Inc (OVID) is listed at https://lician.com/news/ovid. Filings: https://lician.com/sec/ovid
Not investment advice.